Nutritional composition for improving the mammalian immune system
First Claim
Patent Images
1. A method for treating neutropenia in a mammal, comprising administering a nutritional composition to the mammal in need thereof, said nutritional composition comprising:
- (a) 18-50 en % of proteinaceous matter;
(b) at least 12 wt % of leucine, based on total proteinaceous matter;
(c) 10-50 en % of lipids, said lipids comprise at least 15 wt % based on total lipid content of a ω
-3 polyunsaturated fatty acid selected from eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid;
(d) 20-50 en % of digestible carbohydrates;
(e) 1-15 wt % of indigestible galactooligosaccharide and fructooligosaccharide, based on total dry matter, the molar ratio of said galactooligosaccharide and fructooligosaccharide ranges from 1;
1 to 20;
1, said nutritional composition has an energetic value of between 0.3 kcal/ml and 3.0 kcal/ml if it is provided as a liquid nutritional composition or an energetic value of between 3.2 kcal/g and 8.0 kcal/g if it is provided as a semi-liquid, gel or solid nutritional composition.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a nutritional composition comprising
- (a) at least 18 en % of proteinaceous matter;
- (b) at least 12 wt % of leucine, based on total proteinaceous matter;
- (c) a lipid fraction comprising at least a ω-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid;
- (d) an immune modulator;
- for improving the immune function in a mammal, preferably a human.
2 Citations
24 Claims
-
1. A method for treating neutropenia in a mammal, comprising administering a nutritional composition to the mammal in need thereof, said nutritional composition comprising:
-
(a) 18-50 en % of proteinaceous matter; (b) at least 12 wt % of leucine, based on total proteinaceous matter; (c) 10-50 en % of lipids, said lipids comprise at least 15 wt % based on total lipid content of a ω
-3 polyunsaturated fatty acid selected from eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid;(d) 20-50 en % of digestible carbohydrates; (e) 1-15 wt % of indigestible galactooligosaccharide and fructooligosaccharide, based on total dry matter, the molar ratio of said galactooligosaccharide and fructooligosaccharide ranges from 1;
1 to 20;
1, said nutritional composition has an energetic value of between 0.3 kcal/ml and 3.0 kcal/ml if it is provided as a liquid nutritional composition or an energetic value of between 3.2 kcal/g and 8.0 kcal/g if it is provided as a semi-liquid, gel or solid nutritional composition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
Specification